It’s all speculation. Joe said that shareholders have about 6%. Well if 8M shares is 6%, then 100% is 133M shares. If we need $4 for nasdaq, then that values NGIO at $532M. I don’t know if the old antigen express is worth that right now. So if we merge with someone, do we keep our 6% ownership and have a piece of their assets/revenue potential? We just don’t know everything and probably won’t until we get a definitive direction from GNBT.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.